14-53054467-T-C

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001160148.2(DDHD1):ā€‹c.2408A>Gā€‹(p.His803Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,613,902 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00065 ( 0 hom., cov: 32)
Exomes š‘“: 0.0012 ( 3 hom. )

Consequence

DDHD1
NM_001160148.2 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 1.53
Variant links:
Genes affected
DDHD1 (HGNC:19714): (DDHD domain containing 1) This gene is a member of the intracellular phospholipase A1 gene family. The protein encoded by this gene preferentially hydrolyzes phosphatidic acid. It is a cytosolic protein with some mitochondrial localization, and is thought to be involved in the regulation of mitochondrial dynamics. Overexpression of this gene causes fragmentation of the tubular structures in mitochondria, while depletion of the gene results in mitochondrial tubule elongation. Deletion of this gene in male mice caused fertility defects, resulting from disruption in the organization of the mitochondria during spermiogenesis. In humans, mutations in this gene have been associated with hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, or, familial spastic paraparesis (FSP). This inherited disorder is characterized by progressive weakness and spasticity of the legs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012069315).
BP6
Variant 14-53054467-T-C is Benign according to our data. Variant chr14-53054467-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 464309.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Likely_benign=1, Uncertain_significance=3}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00065 (99/152200) while in subpopulation NFE AF= 0.00106 (72/68028). AF 95% confidence interval is 0.000861. There are 0 homozygotes in gnomad4. There are 44 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DDHD1NM_001160148.2 linkuse as main transcriptc.2408A>G p.His803Arg missense_variant 11/13 ENST00000673822.2 NP_001153620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DDHD1ENST00000673822.2 linkuse as main transcriptc.2408A>G p.His803Arg missense_variant 11/13 NM_001160148.2 ENSP00000500986 A2Q8NEL9-1

Frequencies

GnomAD3 genomes
AF:
0.000650
AC:
99
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00106
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000668
AC:
168
AN:
251324
Hom.:
1
AF XY:
0.000545
AC XY:
74
AN XY:
135824
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000968
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.00120
AC:
1750
AN:
1461702
Hom.:
3
Cov.:
30
AF XY:
0.00114
AC XY:
830
AN XY:
727130
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000537
Gnomad4 ASJ exome
AF:
0.00249
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00140
Gnomad4 OTH exome
AF:
0.00152
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152200
Hom.:
0
Cov.:
32
AF XY:
0.000592
AC XY:
44
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.000393
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00106
Gnomad4 OTH
AF:
0.00143
Alfa
AF:
0.000938
Hom.:
0
Bravo
AF:
0.000752
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.000675
AC:
82
EpiCase
AF:
0.00120
EpiControl
AF:
0.00136

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024DDHD1: BP4 -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicDec 06, 2022BP4 -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 17, 2021The c.2408A>G (p.H803R) alteration is located in exon 11 (coding exon 11) of the DDHD1 gene. This alteration results from a A to G substitution at nucleotide position 2408, causing the histidine (H) at amino acid position 803 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenDec 16, 2016- -
DDHD1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 14, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hereditary spastic paraplegia 28 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Benign
0.79
DEOGEN2
Benign
0.15
.;.;T;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.090
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.79
T;T;T;T
M_CAP
Benign
0.0030
T
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.32
.;.;N;N
MutationTaster
Benign
0.84
D;D;D
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.0
.;N;N;N
REVEL
Benign
0.061
Sift
Benign
0.25
.;T;T;T
Sift4G
Benign
0.26
T;T;T;T
Polyphen
0.0
.;.;B;B
Vest4
0.14
MVP
0.093
MPC
0.54
ClinPred
0.0085
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.051
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144016130; hg19: chr14-53521185; API